---
title: "Plus Therapeutics rebrands as Cerenome, to trade as CNSY on Nasdaq from Aug. 3, 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291274838.md"
description: "Plus Therapeutics is rebranding as Cerenome, transitioning to an integrated CNS oncology platform. The Nasdaq ticker will change from PSTV to CNSY effective August 3, 2026. No shareholder action is required for this name and symbol change."
datetime: "2026-06-30T11:31:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291274838.md)
  - [en](https://longbridge.com/en/news/291274838.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291274838.md)
---

# Plus Therapeutics rebrands as Cerenome, to trade as CNSY on Nasdaq from Aug. 3, 2026

-   Plus Therapeutics to rebrand as Cerenome, shifting its corporate identity to an integrated CNS oncology platform spanning therapeutics, diagnostics, data, AI. \* Nasdaq ticker to change to CNSY from PSTV on Aug. 3, 2026; shares expected to begin trading under the new symbol then. \* No shareholder action required for the name or ticker change. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Plus Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606300730PRIMZONEFULLFEED9754521) on June 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [PSTV.US](https://longbridge.com/en/quote/PSTV.US.md)
- [CNSY.US](https://longbridge.com/en/quote/CNSY.US.md)

## Related News & Research

- [Cerenome Launches as an Integrated CNS Oncology Company | PSTV Stock News](https://longbridge.com/en/news/294514925.md)
- [ERG announces availability of H1 2026 interim financial report](https://longbridge.com/en/news/294572882.md)
- [Baxter Q2 2026 Earnings Preview](https://longbridge.com/en/news/294224876.md)
- [Banco BPM schedules H1 2026 results presentation call](https://longbridge.com/en/news/294501538.md)
- [EXPO: Double-digit growth in Q2 2026, raised 2026 guidance, and strong AI-driven demand](https://longbridge.com/en/news/294421668.md)